JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
6201
PUT
KE Holdings
BEKE
$18.3B
| $7.37K | ﹤0.01% |
400
-60,000
| -99% | -$1.24M |
2024 Q3
1 quarter
|
|
|
CRON
6202
Cronos Group
CRON
$1.18B
| $7.34K | ﹤0.01% |
3,633
+200
| +6% | +$417 |
2019 Q1
23 quarters
|
|
6203
First Trust Switzerland AlphaDEX Fund
FSZ
$35.1M
| $7.28K | ﹤0.01% |
115
| – | – |
2023 Q3
5 quarters
|
|
6204
ProShares Short SmallCap600
SBB
$3.63M
| $7.25K | ﹤0.01% |
248
| – | – |
2023 Q3
5 quarters
|
|
|
PSFE.WS
6205
DELISTED
Paysafe Ltd Warrants
PSFE.WS
| – | – |
0
| – | – |
2024 Q4
0 quarters
|
|
6206
ProShares Short Russell2000
RWM
$156M
| $7.12K | ﹤0.01% |
+380
| New | +$6.99K |
2024 Q4
0 quarters
|
|
6207
Rockwell Medical
RMTI
$34.5M
| $7.06K | ﹤0.01% |
346
-4,361
| -93% | -$127K |
2013 Q2
46 quarters
|
|
6208
First Trust Developed Markets ex-US AlphaDEX Fund
FDT
$1.34B
| $7.06K | ﹤0.01% |
130
-1
| -0.8% | -$56 |
2023 Q1
7 quarters
|
|
|
BSJP
6209
DELISTED
Invesco BulletShares 2025 High Yield Corporate Bond ETF
BSJP
| $6.99K | ﹤0.01% |
+303
| New | +$7K |
2024 Q4
0 quarters
|
|
6210
Innovator US Equity Buffer ETF February
BFEB
$207M
| $6.89K | ﹤0.01% |
160
-14,288
| -99% | -$608K |
2024 Q2
2 quarters
|
|
|
GAU
6211
Galiano Gold
GAU
$510M
| $6.82K | ﹤0.01% |
5,547
-97,653
| -95% | -$141K |
2024 Q3
1 quarter
|
|
|
ZNB
6212
Zeta Network Group
ZNB
$1.03M
| – | – |
0
| – | – |
2024 Q4
0 quarters
|
|
6213
Aterian
ATER
$11M
| $6.72K | ﹤0.01% |
2,800
| – | – |
2020 Q3
17 quarters
|
|
6214
Invesco Global Water ETF
PIO
$259M
| $6.72K | ﹤0.01% |
172
-600
| -78% | -$24.7K |
2023 Q2
6 quarters
|
|
6215
Verrica Pharmaceuticals
VRCA
$77.5M
| $6.66K | ﹤0.01% |
952
+65
| +7% | +$714 |
2018 Q3
25 quarters
|
|
6216
Century Casinos
CNTY
$29.5M
| $6.62K | ﹤0.01% |
2,042
-592
| -22% | -$2.08K |
2017 Q4
28 quarters
|
|
|
BUJAW
6217
DELISTED
Bukit Jalil Global Acquisition 1 Ltd. Warrants
BUJAW
| – | – |
0
| – | – |
2024 Q4
0 quarters
|
|
6218
Fidelity Tactical Bond ETF
FTBD
$37.5M
| $6.61K | ﹤0.01% |
+137
| New | +$6.74K |
2024 Q4
0 quarters
|
|
6219
BlackRock Enhanced Equity Dividend Trust
BDJ
$1.67B
| $6.58K | ﹤0.01% |
795
-4,744
| -86% | -$41.3K |
2024 Q1
3 quarters
|
|
6220
Invesco Floating Rate Municipal Income ETF
PVI
$31.1M
| $6.57K | ﹤0.01% |
266
| – | – |
2024 Q3
1 quarter
|
|
|
PZC
6221
DELISTED
PIMCO California Municipal Income Fund III
PZC
| $6.55K | ﹤0.01% |
+953
| New | +$6.86K |
2024 Q4
0 quarters
|
|
6222
IceCure Medical
ICCM
$7.84M
| $6.54K | ﹤0.01% |
198
| – | – |
2023 Q3
5 quarters
|
|
6223
CALL
Wendy's
WEN
$1.19B
| $6.52K | ﹤0.01% |
400
| – | – |
2024 Q3
1 quarter
|
|
|
6224
PUT
Wendy's
WEN
$1.19B
| $6.52K | ﹤0.01% |
400
| – | – |
2024 Q3
1 quarter
|
|
6225
Global X DAX Germany ETF
DAX
$209M
| $6.5K | ﹤0.01% |
+195
| New | +$6.61K |
2024 Q4
0 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.